C22H28N6O8
504.5 g/mol
APIDanger
Tofacitinib citrate
CAS540737-29-9
Category
API
Compound Class
Other
Primary Use
Pharmaceutical Raw Material
Tofacitinib citrate is a salt form of tofacitinib, an active pharmaceutical ingredient used as an immunosuppressant. It is supplied as a pharmaceutical raw material for manufacturing purposes.
raw material for immunosuppressant drug products
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 540737-29-9
Related Compounds
StrongSame Parent
Tofacitinib
CAS477600-75-2
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.78
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
CAS1675248-19-7
pharmaceutical intermediate
ReferenceSame Category
L-carnitine
CAS541-15-1
pharmaceutical raw material
ReferenceSame Category
Pentamethonium bromide
CAS541-20-8
pharmaceutical raw material
ReferenceSame Category
Benzphetamine hydrochloride
CAS5411-22-3
pharmaceutical raw material
ReferenceSame Category
Butinoline phosphate
CAS54118-66-0
pharmaceutical raw material
Referencestereoisomer of
(3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile
CAS1092578-47-6
pharmaceutical raw material
Referencesame scaffold
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
CAS1260590-51-9
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H360May damage fertility or the unborn child
Identifiers
IUPAC Name
2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
InChIKey
SYIKUFDOYJFGBQ-YLAFAASESA-N
SMILES
C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
Synonyms (29)
- Tofacitinib citrate (JAN/USAN)
- 540737-29-9 (citrate)
- CP-690,550-10
- CP-690550 citrate
- Racemic Tasocitinib
- Tasocitinib citrate
- Tasocitinib citric acid salt
- Tasocitinib monocitrate
- Tofacitinib citrate
- Tofacitinib monocitrate
- Xeljanz
- Xeljanz (TN)
- Xeljanz Xr